Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Creative Enzymes Releases Restriction Enzymes for Molecular Biology Research

Creative Enzymes, an excellent biotech company specializing in enzyme manufacturing and offering related services, is excited to introduce a new line of restriction enzymes designed to enhance the flexibility and precision of molecular biology experiments.

New York, United States - March 1, 2023 /MarketersMEDIA/

Creative Enzymes, an excellent biotech company specializing in enzyme manufacturing and offering related services, is excited to introduce a new line of restriction enzymes designed to enhance the flexibility and precision of molecular biology experiments. Restriction enzymes are essential tools for DNA digestion in molecular biology research, allowing scientists to modify, cleave, and analyze DNA fragments with exceptional accuracy and efficiency.

As research in genetic engineering and DNA sequencing grows more complex and sophisticated, the need for advanced restriction enzymes has never been more pressing. To meet this demand, Creative Enzymes has developed a range of innovative restriction enzymes that provide superior performance and versatility. These enzymes are derived from various sources, including bacteria, fungi, and plants, and are engineered to display exceptional specificity, sensitivity, and stability under a wide range of conditions.

The highlighted restriction enzymes cover the followings:

AccBSI is a high-fidelity endonuclease that recognizes the sequence CC*TCGAGG and cleaves the DNA double-strands precisely. This enzyme is particularly useful for applications that require precise control over DNA cleavages, such as site-directed mutagenesis and gene synthesis.

BseX3I is a rare-restriction enzyme that recognizes the sequence AACGTT and cleaves DNA only once every 4096 base pairs. This enzyme is ideal for applications that require long DNA fragments, such as genome assembly and DNA sequencing.

BstFNI is a thermostable enzyme that recognizes the sequence CCTNAGG and cleaves DNA at a defined position, leaving a 4-base overhang. This enzyme is beneficial for applications that require high-temperature incubation, such as PCR amplification and DNA ligation.

“We are excited to introduce our latest line of restriction enzymes to the scientific community,” said the senior scientist at Creative Enzymes. “These enzymes provide researchers unparalleled precision, specificity, and efficiency in molecular biology experiments, enabling them to achieve results that were previously thought to be impossible.”

With the launch of these innovative restriction enzymes, Creative Enzymes reaffirms its commitment to providing high-quality enzyme products and services to researchers worldwide. The company’s expert team of scientists and technicians is dedicated to helping customers overcome the most challenging research obstacles and achieve breakthrough discoveries in a wide range of fields, including biotechnology, pharmaceuticals, and agriculture.

About Creative Enzymes

Creative Enzymes is a remarkable supplier and manufacturer in the enzymology field. Equipped with an advanced technology platform, Creative Enzymes is able to offer high-quality and professional services to customers. Lastly, its products and services have been widely used in the academic and pharmaceutical industries.

Contact Info:
Name: Iva Colter
Email: Send Email
Organization: Creative Enzymes
Website: https://www.creative-enzymes.com/

Release ID: 89091143

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.